Swiss Re Tackles Longevity Drug Impact With Life Policy Advice
Insurance Journal - Aug 12, 2025
Swiss Re AG issued guidance for underwriters on how to assess life insurance applications of people who show signs of using medications for longevity purposes. Metformin, traditionally used to manage type 2 diabetes, and rapamycin, an immunosuppressant developed for organ …...
Recommended Articles
Posted: Nov 03, 2025
The Paris prosecutor said Saturday two new suspects were handed preliminary charges for their allege...
Posted: Nov 03, 2025
AXA XL announced the launch of a new cyber solution designed to provide construction firms in Europe...
Posted: Nov 03, 2025
H.W. Kaufman Group Makes Promotions Across Executive and North American Teams H.W. Kaufman Group, he...